Literature DB >> 29911319

Inhibitory control in typically developing preschoolers: Relations among temperament, respiratory sinus arrhythmia, and behavior at age 4.

Raha Hassan1, Kimberly L Day2, Ryan J Van Lieshout3, Louis A Schmidt1.   

Abstract

Although inhibitory control (IC) is associated with children's positive adjustment, we know relatively little about factors underlying its development. We examined whether baseline and on-task respiratory sinus arrhythmia [(RSA); a physiological measure of self-regulation] and private speech (a behavioral measure of self-regulation) interacted to confer differences on directly observed IC in 52 typically developing 4-year olds. We found that baseline RSA moderated the association between private speech and IC, such that private speech positively predicted IC in children with relatively higher baseline RSA, but was unrelated to IC in children with relatively lower RSA. We also found that children with a concordant physiological-behavioral pattern (i.e., high RSA and high private speech; low RSA and low private speech) had higher IC, higher effortful control, and lower negative emotionality than those with a discordant physiological-behavioral pattern (i.e., high RSA and low private speech; low RSA and high private speech). Individual differences in physiological and behavioral self-regulation indices may represent distinct regulation pathways that interact to confer differences in IC during the preschool years.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  inhibitory control; preschoolers; respiratory sinus arrhythmia; self-regulation; temperament

Mesh:

Year:  2018        PMID: 29911319     DOI: 10.1002/dev.21740

Source DB:  PubMed          Journal:  Dev Psychobiol        ISSN: 0012-1630            Impact factor:   3.038


  1 in total

1.  Private Speech and the Development of Self-Regulation: The Importance of Temperamental Anger.

Authors:  Margaret Whedon; Nicole B Perry; Erica B Curtis; Martha Ann Bell
Journal:  Early Child Res Q       Date:  2021-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.